Oramed Pharmaceuticals Inc (ORMP) — Free Cash Flow Generation Index

Latest as of June 2024: 1.00x

Oramed Pharmaceuticals Inc (ORMP) has a Free Cash Flow Generation Index of 1.00x as of June 2024. Free cash flow of $2.07 Million represents 1% of operating cash flow ($2.07 Million). Explore Oramed Pharmaceuticals Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$2.07 Million
USD

Operating Cash Flow

$2.07 Million
USD

Capital Expenditures

$17.06
USD

Oramed Pharmaceuticals Inc Free Cash Flow Generation Index (2016–2016)

Historical FCF Generation Index trend for Oramed Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Oramed Pharmaceuticals Inc.

Annual Free Cash Flow Generation for Oramed Pharmaceuticals Inc (2016–2016)

Year-by-year Free Cash Flow Generation Index for Oramed Pharmaceuticals Inc. Check Oramed Pharmaceuticals Inc (ORMP) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2016 1.00x $4.65 Million $4.66 Million $9.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).